Categories AlphaGraphs, Earnings, Health Care
Key highlights from Abbott Laboratories (ABT) Q2 2023 earnings results
Abbott Laboratories (NYSE: ABT) reported second quarter 2023 earnings results today.
Net sales decreased 11.4% year-over-year to $10 billion. Organic sales growth, excluding COVID-19 tests, was 11.5%.
GAAP net income decreased 32% to $1.37 billion, or $0.78 per share, from last year. Adjusted EPS fell 24.5% to $1.08.
For full-year 2023, adjusted EPS is expected to range between $4.30-4.50.
Prior performance
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
